For Release on Dec 18, 2017
DALLAS, TX, December 18, 2017 – PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named BioLum Sciences as one of the most innovative Startups of 2017.
BioLum Sciences’s device allows asthmatics to monitor the presence and severity of lung stress, ultimately enabling them to personalize treatment plans and reduce costly asthmatic episodes. Patients can analyze their breath with BioLum’s device and receive a reading that indicates the presence and severity of their airway inflammation in less than 2 minutes. BioLum Sciences has been identified as a top, innovative startup in several national and global competitions and awards, winning over $100,000 in prize money. Currently BioLum’s BioSense AMD (Airway Monitoring Device) is a few final developments away from being complete.
Edward Allegra, co-founder and CEO of BioLum Sciences, said in a statement: “It is an honor to be recognized among these innovative healthcare startups, and we look forward to continued success going into the new year.”
BioLum Sciences was selected as part of PM360’s 6th Annual Innovations Issue published each December. This issue was established to serve as a guide to the year’s most innovative Companies, Startups, Divisions, Products, Services, and Strategies from within the healthcare and life sciences industries. This comprehensive overview of the year’s most innovative achievements in these six categories helps other companies in the industry to find potential partners and offerings that can help them advance healthcare and life sciences.
“Each of this year’s selections showcases our industry’s strong desire to constantly find new ways to advance every sector of life sciences from development to marketing to philanthropy and much more,” says Anna Stashower, CEO/Publisher of PM360. “We are excited to showcase these innovative achievements and help get the word out about companies and offerings that help make the job easier for others working in our industry.”
PM360 received hundreds of submissions from across the healthcare and life sciences industries. The editorial staff of PM360 evaluated each submission and selected their picks for the most innovative, regardless of category. Ultimately, the final selections represent the most exciting innovations from 2017.
All of this year’s selections can be found at: www.pm360online.com/pm360-presents-the-2017-innovators
About BioLum Sciences
BioLum Sciences, LLC is the developer of a medical device, the BioSense AMD (Airway Monitoring Device), that aids in the diagnosis and monitoring of respiratory diseases, such as asthma and COPD, by enabling patients to measure airway inflammation with a quick and reliable test.
BioLum’s team comprises an effective partnership between entrepreneurial expertise and scientific innovation. BioLum has capitalized on the thriving business sector in the Dallas area to forge partnerships and a strong consultant network.
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Contact: Edward Allegra
Mobile: (732)-284-7042
Email: ecallegra@biolumsciences.com